Skip to main content
Addgene
Showing: 241 - 260 of 332 results
  1. pAAV_BiCHATe27_dTomato_nlsdTomato (AAV PHP.eB)

    Viral Prep
    #213829-PHPeB
    Purpose
    Ready-to-use AAV PHP.eB particles produced from pAAV_BiCHATe27_dTomato_nlsdTomato (#213829). In addition to the viral particles, you will also receive purified pAAV_BiCHATe27_dTomato_nlsdTomato plasmid DNA. Bicistronic expression of dTomato and nuclear-targeted dTomato under the control of the cholinergic neuron-targeting enhancer E27. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    Tags
    dTomato
    Available since
    Dec. 2, 2024
    Availability
    Academic Institutions and Nonprofits only
  2. pAAV_BiPVe4_dTomato_nlsdTomato (AAV PHP.eB)

    Viral Prep
    #213936-PHPeB
    Purpose
    Ready-to-use AAV PHP.eB particles produced from pAAV_BiPVe4_dTomato_nlsdTomato (#213936). In addition to the viral particles, you will also receive purified pAAV_BiPVe4_dTomato_nlsdTomato plasmid DNA. Bicistronic expression of dTomato and nuclear-targeted dTomato under the control of the chandelier cell-targeting enhancer E4. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    Tags
    dTomato
    Available since
    Dec. 2, 2024
    Availability
    Academic Institutions and Nonprofits only
  3. pAAV_BiVIPe4_dTomato_nlsdTomato (AAV PHP.eB)

    Viral Prep
    #213855-PHPeB
    Purpose
    Ready-to-use AAV PHP.eB particles produced from pAAV_BiVIPe4_dTomato_nlsdTomato (#213855). In addition to the viral particles, you will also receive purified pAAV_BiVIPe4_dTomato_nlsdTomato plasmid DNA. Bicistronic expression of dTomato and nuclear-targeted dTomato under the control of the VIP interneuron-targeting enhancer E4. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    Tags
    dTomato
    Available since
    Dec. 2, 2024
    Availability
    Academic Institutions and Nonprofits only
  4. pAAV_BiSSTe10_dTomato_nlsdTomato (AAV PHP.eB)

    Viral Prep
    #213814-PHPeB
    Purpose
    Ready-to-use AAV PHP.eB particles produced from pAAV_BiSSTe10_dTomato_nlsdTomato (#213814). In addition to the viral particles, you will also receive purified pAAV_BiSSTe10_dTomato_nlsdTomato plasmid DNA. Bicistronic expression of dTomato and nuclear-targeted dTomato under the control of the SST interneuron-targeting enhancer E10. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    Tags
    dTomato
    Available since
    Dec. 2, 2024
    Availability
    Academic Institutions and Nonprofits only
  5. pAAV.CMV.PI.EGFP.WPRE.bGH (AAV9)

    Viral Prep
    #105530-AAV9
    Purpose
    Ready-to-use AAV9 particles produced from pAAV.CMV.PI.EGFP.WPRE.bGH (#105530). In addition to the viral particles, you will also receive purified pAAV.CMV.PI.EGFP.WPRE.bGH plasmid DNA. CMV-driven EGFP control. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CMV
    Tags
    EGFP
    Available since
    July 13, 2018
    Availability
    Academic Institutions and Nonprofits only
  6. pAAV.CMV.PI.EGFP.WPRE.bGH (AAV1)

    Viral Prep
    #105530-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV.CMV.PI.EGFP.WPRE.bGH (#105530). In addition to the viral particles, you will also receive purified pAAV.CMV.PI.EGFP.WPRE.bGH plasmid DNA. CMV-driven EGFP control. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CMV
    Tags
    EGFP
    Available since
    March 26, 2019
    Availability
    Academic Institutions and Nonprofits only
  7. pAAV.CMV.PI.EGFP.WPRE.bGH (AAV2)

    Viral Prep
    #105530-AAV2
    Purpose
    Ready-to-use AAV2 particles produced from pAAV.CMV.PI.EGFP.WPRE.bGH (#105530). In addition to the viral particles, you will also receive purified pAAV.CMV.PI.EGFP.WPRE.bGH plasmid DNA. CMV-driven EGFP control. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CMV
    Tags
    EGFP
    Available since
    June 29, 2018
    Availability
    Academic Institutions and Nonprofits only
  8. pAAV.CMV.PI.EGFP.WPRE.bGH (AAV8)

    Viral Prep
    #105530-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from pAAV.CMV.PI.EGFP.WPRE.bGH (#105530). In addition to the viral particles, you will also receive purified pAAV.CMV.PI.EGFP.WPRE.bGH plasmid DNA. CMV-driven EGFP control. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CMV
    Tags
    EGFP
    Available since
    June 29, 2018
    Availability
    Academic Institutions and Nonprofits only
  9. pAAV.CMV.PI.EGFP.WPRE.bGH (AAV5)

    Viral Prep
    #105530-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pAAV.CMV.PI.EGFP.WPRE.bGH (#105530). In addition to the viral particles, you will also receive purified pAAV.CMV.PI.EGFP.WPRE.bGH plasmid DNA. CMV-driven EGFP control. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CMV
    Tags
    EGFP
    Available since
    June 1, 2018
    Availability
    Academic Institutions and Nonprofits only
  10. pAAV.CMV.ffLuciferase.SV40 (AAV8)

    Viral Prep
    #105532-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from pAAV.CMV.ffLuciferase.SV40 (#105532). In addition to the viral particles, you will also receive purified pAAV.CMV.ffLuciferase.SV40 plasmid DNA. CMV-driven ffLuciferase control. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CMV
    Tags
    ffLuciferase
    Available since
    June 29, 2018
    Availability
    Academic Institutions and Nonprofits only
  11. pAAV.CMV.LacZ.bGH (AAV8)

    Viral Prep
    #105531-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from pAAV.CMV.LacZ.bGH (#105531). In addition to the viral particles, you will also receive purified pAAV.CMV.LacZ.bGH plasmid DNA. CMV-driven LacZ expression control. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CMV
    Tags
    LacZ
    Available since
    June 29, 2018
    Availability
    Academic Institutions and Nonprofits only
  12. pAAV.CMV.LacZ.bGH (AAV5)

    Viral Prep
    #105531-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pAAV.CMV.LacZ.bGH (#105531). In addition to the viral particles, you will also receive purified pAAV.CMV.LacZ.bGH plasmid DNA. CMV-driven LacZ expression control. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CMV
    Tags
    LacZ
    Available since
    July 11, 2018
    Availability
    Academic Institutions and Nonprofits only
  13. pAAV.CMV.PI.EGFP.WPRE.bGH (AAV rh10)

    Viral Prep
    #105530-rh10
    Purpose
    Ready-to-use AAV rh10 (similar to AAV10) particles produced from pAAV.CMV.PI.EGFP.WPRE.bGH (#105530). In addition to the viral particles, you will also receive purified pAAV.CMV.PI.EGFP.WPRE.bGH plasmid DNA. CMV-driven EGFP control. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CMV
    Tags
    EGFP
    Available since
    June 29, 2018
    Availability
    Academic Institutions and Nonprofits only
  14. pAAV.CMV.PI.EGFP.WPRE.bGH (AAV PHP.eB)

    Viral Prep
    #105530-PHPeB
    Purpose
    Ready-to-use AAV PHP.eB particles produced from pAAV.CMV.PI.EGFP.WPRE.bGH (#105530). In addition to the viral particles, you will also receive purified pAAV.CMV.PI.EGFP.WPRE.bGH plasmid DNA. CMV-driven EGFP control. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CMV
    Tags
    EGFP
    Available since
    Feb. 16, 2024
    Availability
    Academic Institutions and Nonprofits only
  15. pAAV-CaMKIIa-EGFP (AAV9)

    Viral Prep
    #50469-AAV9
    Purpose
    Ready-to-use AAV9 particles produced from pAAV-CaMKIIa-EGFP (#50469). In addition to the viral particles, you will also receive purified pAAV-CaMKIIa-EGFP plasmid DNA. CamKIIa-driven EGFP expression control. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CaMKII
    Tags
    EGFP
    Available since
    Jan. 6, 2022
    Availability
    Academic Institutions and Nonprofits only
  16. pAAV-CaMKIIa-EGFP (AAV5)

    Viral Prep
    #50469-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pAAV-CaMKIIa-EGFP (#50469). In addition to the viral particles, you will also receive purified pAAV-CaMKIIa-EGFP plasmid DNA. CamKIIa-driven EGFP expression control. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CaMKII
    Tags
    EGFP
    Available since
    Nov. 21, 2016
    Availability
    Academic Institutions and Nonprofits only
  17. pAAV-CaMKIIa-EGFP (AAV8)

    Viral Prep
    #50469-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from pAAV-CaMKIIa-EGFP (#50469). In addition to the viral particles, you will also receive purified pAAV-CaMKIIa-EGFP plasmid DNA. CamKIIa-driven EGFP expression control. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CaMKII
    Tags
    EGFP
    Available since
    Nov. 8, 2016
    Availability
    Academic Institutions and Nonprofits only
  18. pAAV-CaMKIIa-EGFP (AAV1)

    Viral Prep
    #50469-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-CaMKIIa-EGFP (#50469). In addition to the viral particles, you will also receive purified pAAV-CaMKIIa-EGFP plasmid DNA. CamKIIa-driven EGFP expression control. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CaMKII
    Tags
    EGFP
    Available since
    Sept. 27, 2024
    Availability
    Academic Institutions and Nonprofits only
  19. pAAV-CaMKIIa-EGFP (AAV2)

    Viral Prep
    #50469-AAV2
    Purpose
    Ready-to-use AAV2 particles produced from pAAV-CaMKIIa-EGFP (#50469). In addition to the viral particles, you will also receive purified pAAV-CaMKIIa-EGFP plasmid DNA. CamKIIa-driven EGFP expression control. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CaMKII
    Tags
    EGFP
    Available since
    Jan. 6, 2022
    Availability
    Academic Institutions and Nonprofits only
  20. pAAV-CAG-tdTomato (codon diversified) (AAV9)

    Viral Prep
    #59462-AAV9
    Purpose
    Ready-to-use AAV9 particles produced from pAAV-CAG-tdTomato (codon diversified) (#59462). In addition to the viral particles, you will also receive purified pAAV-CAG-tdTomato (codon diversified) plasmid DNA. CAG-driven tdTomato expression control. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CAG
    Tags
    tdTomato (codon diversified)
    Available since
    Jan. 26, 2021
    Availability
    Academic Institutions and Nonprofits only
Showing: 241 - 260 of 332 results